Market Movers: NextGen Healthcare (NXGN) Jumps 3.84% to Close at $19.74 May 13

Equities Staff  |

NextGen Healthcare Inc (NASDAQ:NXGN) stock was among today's market movers, concluding trading up 3.84% to $19.74 on May 13.

442,931 shares traded today in comparison to the 30-day daily average of 326,737 shares.

The company's stock has risen 6.86% so far in 2022.

NextGen Healthcare shares have moved between $13.64 and $21.87 over the past twelve months.

The company expects its next earnings on 2022-05-17.

For technical charts, analysis, and more on NextGen Healthcare visit the company profile.

About NextGen Healthcare Inc

NextGen Healthcare, Inc. is a leading provider of ambulatory-focused technology solutions. It is empowering the transformation of ambulatory care-partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. It goes beyond EHR and PM. Its integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. It believes in better.

To get more information on NextGen Healthcare Inc and to follow the company's latest updates, you can visit the company's profile page here: NextGen Healthcare Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement



Market Movers

Sponsored Financial Content